×
For best experience we recommend to activate Javascript in your browser.
Recombinant TIM3 (Cobolimab Biosimilar) antibody (Alexa Fluor 488)
The Humanized Monoclonal anti-TIM3 (Cobolimab Biosimilar) antibody is suitable to detect TIM3 (Cobolimab Biosimilar) in samples from Human. It has been validated for ELISA, FACS and CyTox.
Catalog No. ABIN7766353
$515.90
Plus shipping costs $50.00
Delivery in 6 to 9 Business Days
Quick Overview for Recombinant TIM3 (Cobolimab Biosimilar) antibody (Alexa Fluor 488) (ABIN7766353)
Target
TIM3 (Cobolimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for TIM3 (Cobolimab Biosimilar) antibodies
Humanized
Clonality
All clonalities for TIM3 (Cobolimab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for TIM3 (Cobolimab Biosimilar) antibodies
This TIM3 (Cobolimab Biosimilar) antibody is conjugated to Alexa Fluor 488
Application
All applications for TIM3 (Cobolimab Biosimilar) antibodies
ELISA, Flow Cytometry (FACS), Cytotoxicity Test (CyTox)
Product Details anti-TIM3 (Cobolimab Biosimilar) Antibody (Alexa Fluor 488)
(hide)
Purpose
Conjugated Anti-TIM3 (cobolimab biosimilar) mAb
Purification
Purified from cell culture supernatant by affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
most applications: 1: 50 - 1: 250
Restrictions
For Research Use only
Handling
(hide)
Buffer
Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Protect from light!
Storage
4 °C
Storage Comment
Store at 4°C in dark for 6 months
Target Details for TIM3 (Cobolimab Biosimilar)
(hide)
Target
TIM3 (Cobolimab Biosimilar)
Alternative Name
cobolimab biosimilar
Target Type
Biosimilar
Background
HAVCR2, TIM3, TIMD3, FLJ14428, KIM3
Recently viewed
(hide)
You are here:
Homepage
Recombinant anti-TIM3 (Cobolimab Biosimilar) antibody (Alexa Fluor 488) (ABIN7766353)
Chat with us , powered by LiveChat